Clinical trial Recruiting at 1 site Observational Ages 18 and up

Exploring kinocardiography for diagnosing aortic valve disease and aneurysms

Official title: Impact of Aortic Valve Disease and Thoracic Aortic Aneurysm on Kinocardiographic Signals

Run by Université Libre de Bruxelles · NCT06286358 · Data updated 2026-11-12

This study is testing if kinocardiography can help doctors better diagnose aortic valve disease and aortic aneurysms in patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorUniversité Libre de Bruxelles
Academic / other
Locations1 site (Brussels)
StatusRecruiting
StartedMarch 7, 2024
Main results expectedOctober 5, 2026
Study endsDecember 30, 2026
Registry record updatedMay 1, 2026
Trial IDNCT06286358 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years with severe aortic valve disease or thoracic aortic aneurysm, as well as those with varying severities of aortic stenosis or regurgitation.

Probably not a fit

Patients with severe rhythm disorders or those unable to provide consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the use of kinocardiography (KCG) in diagnosing aortic valve disease (AVD) and thoracic aortic aneurysm (TAA). Researchers will collect data from patients with varying severities of AVD and TAA, utilizing echocardiography, cardiac MRI, KCG recordings, and phonocardiography. By comparing these patients to a control group without AVD or TAA, the study seeks to understand the effectiveness of KCG in identifying these conditions early. The goal is to enhance diagnostic capabilities and improve patient outcomes through better screening methods.

Why it matters

Potential benefit: If successful, this study could lead to earlier and more accurate diagnoses of aortic valve disease and thoracic aortic aneurysms, potentially reducing morbidity and mortality.

How similar studies have gone: While kinocardiography is a novel approach, similar studies using advanced imaging techniques have shown promise in improving diagnostic accuracy for cardiovascular conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* "Interventional treatment" group

  * Adults (\>18 y)
  * Interventional treatment indication for severe AVD and/or severe TAA, as decided by the Heart Team
* "Aortic valve disease of different severities" group

  * Adults (\>18y)
  * Aortic stenosis and/or aortic regurgitation and/or bicuspidy of different severities confirmed by echocardiography and/or cardiac MRI
* "Control" group : - Adults (\>18 y) appariated with the participants of other groups according to their age, sex, body surface area and LVEF

Exclusion Criteria:

* Any severe rhythm disorder such as frequent ventricular extrasystoles, atrial tachyarrhythmias
* Subject's disabilty to give consent
* Subjects suffering from aortic valve disease or thoracic aortic aneurysm will be excluded from the "control" group.

Where it's running

  • Erasme hospital
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.